Acura Pharmaceuticals Change in Inventories 2010-2021 | ACUR

Acura Pharmaceuticals change in inventories from 2010 to 2021. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
Acura Pharmaceuticals Annual Change in Inventories
(Millions of US $)
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.128B 6.91
Dr Reddy's Laboratories (RDY) India $12.012B 21.80
BridgeBio Pharma (BBIO) United States $6.407B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.819B 14.76
Bausch Health Cos (BHC) Canada $1.667B 1.23
Amphastar Pharmaceuticals (AMPH) United States $1.155B 7.70
Taysha Gene Therapies (TSHA) United States $0.525B 0.00
Personalis (PSNL) United States $0.432B 0.00
Assembly Biosciences (ASMB) United States $0.095B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00